Empowering veterinary clinic networks, international pet brand owners, and global procurement buyers with science-led, FEDIAF & AAFCO-aligned therapeutic kibble, private label clinical diets, and contract manufacturing from British facilities.
In an evolving pet care ecosystem where companion animals are increasingly integrated into nuclear families, the global demand for target-driven Clinical Veterinary Pet Nutrition is escalating rapidly. International buyers, veterinary group purchasing organizations (GPOs), and brand founders require manufacturing partners who bridge the gap between academic veterinary dietetics, thermal processing technology, and strict international trade logistics.
At ThePetFoodPeople®, our British manufacturing operations integrate veterinary-led research with specialized twin-screw extrusion capabilities. We produce our own clinical and super-premium brands while serving as an accountable contract manufacturer for global B2B partners.
Our flagship clinical care program engineered specifically for professional veterinary channels. Clinigol® formulations focus on target organ support, including chronic kidney disease (CKD), gastrointestinal recovery, hepatic support, controlled urinary pH management, and severe cutaneous adverse food reactions (CAFR). Built with strictly defined raw material panels and validated by comprehensive laboratory batch testing.
Designed for brands and retail groups seeking hypoallergenic, novel-protein diets with complete ingredient traceability. Clydach Farm® incorporates fresh British lamb, ocean whitefish, and free-range duck paired with functional botanicals, offering a bio-available foundation ideal for sensitive digestive systems and preventative daily wellness diets.
A benchmark range of nutrient-dense kibble engineered for consistent stool density, optimal gut microbiome balance, and high palatability across all life stages. Griffiths’ Dog Food® demonstrates our capability to deliver controlled macro-nutrient architecture at competitive landed costs without sacrificing nutritional integrity.
Designing effective therapeutic diets requires moving far beyond basic commercial kibble manufacturing. It demands absolute control over dietary cation-anion balance (DCAB), amino acid digestibility coefficients, controlled mineral dynamics, and bio-active stability under thermal processing.
Clinical management of acute diarrhea, malabsorption, and inflammatory bowel conditions requires highly digestible ingredient matrices (protein digestibility > 88%). Our GI formulations feature pre-gelatinized clean starches, custom short-chain and medium-chain fatty acid (MCFA) blends, soluble and insoluble fiber ratios (such as beet pulp, psyllium husk, and prebiotic FOS/MOS), and heat-stabilized postbiotics that survive modern extrusion temperatures to reinforce the gut mucosal barrier.
Preserving nephron function in feline and canine patients requires precise restriction of dietary phosphorus (< 0.4% DM in feline renal diets), moderate levels of high-biological-value protein to minimize uremic toxin generation, enriched EPA/DHA omega-3 levels to suppress renal inflammation, and potassium citrate supplementation to manage metabolic acidosis. For urinary lines, precise mineral stoichiometry prevents struvite crystalluria while maintaining target urinary pH (6.2–6.4 for struvite dissolution; 6.5–6.7 for calcium oxalate prevention).
Adverse food reactions (AFR) cause chronic pruritus and cutaneous inflammation. Our technical facility produces strict single-source novel protein formulations (such as insect protein, specialized venison, or cold-water salmon) alongside enzymatic hydrolyzed protein diets. By reducing peptide molecular weight below 10 kDa (Kilodaltons), these clinical diets bypass IgE-mediated immune recognition, serving as reliable diagnostic elimination diets and long-term dermatological management solutions.
Weight management clinical diets combine high dietary fiber and high protein ratios with L-carnitine supplementation to maintain lean muscle mass while facilitating body fat oxidation. Integrated joint care formulas incorporate therapeutic dosages of green-lipped mussel extract, native type-II collagen, glucosamine, chondroitin sulfate, and elevated EPA levels to inhibit cartilage-degrading matrix metalloproteinases (MMPs) in arthritic companion animals.
Global procurement leaders, veterinary clinical chains, and private label importers must align their supply chains with shifting consumer preferences, technological breakthroughs, and stringent global regulatory frameworks.
While live probiotics suffer severe viability loss during high-temperature extrusion and thermal drying, the global clinical veterinary nutrition sector is rapidly transitioning toward postbiotics—inactivated microbial cells, cell wall fragments, and metabolic byproducts (such as short-chain fatty acids). Postbiotics demonstrate extreme thermal stability under twin-screw extrusion parameters, offering consistent gut-brain-axis modulation, systemic anti-inflammatory benefits, and immune system priming across long retail shelf-life windows.
Traditional clinical elimination diets have relied heavily on hydrolyzed poultry liver or traditional fish meals. However, global buyers are now demanding sustainable, hypo-allergenic raw materials such as Hermetia illucens (Black Soldier Fly Larvae) protein hydrolysates and single-origin micro-algae oils. These ingredients yield exceptional amino acid scores, low carbon footprints, and virtually zero risk of environmental cross-contamination with common mammalian allergens (beef, pork, chicken).
Veterinary practitioners frequently encounter geriatric patients suffering from concurrent comorbidities—such as a senior canine presenting with both chronic renal insufficiency and severe osteoarthritis. The market is shifting away from single-disease veterinary diets toward multi-target clinical formulas. Modern procurement contracts prioritize partners capable of balancing complex nutrient profiles, such as maintaining low phosphorus levels for renal care while supplying therapeutic doses of omega-3s and chondroprotectants for joint health within the same kibble matrix.
Institutional purchasers and European supermarket health brands now demand complete supply chain transparency. From farm-level origin verification to heavy metal screening (arsenic, lead, cadmium in ocean fish formulations) and recyclable mono-PE or paper-based barrier bags, clinical veterinary products must satisfy both rigorous medical efficacy standards and strict corporate Environmental, Social, and Governance (ESG) mandates.
Our standardized OEM and contract manufacturing roadmap ensures full compliance, nutritional precision, and risk mitigation for international buyers.
Detailed evaluation of targeted pathological indications, life stage requirements, regional legal frameworks (FEDIAF/AAFCO), target feeding trial benchmarks, and landed cost parameters.
Computerized linear formulation programming by qualified veterinary nutritionists. Raw material specifications, heavy-metal screens, and nutrient tolerance windows are established.
Trial extrusion runs to establish kibble bulk density, starch expansion rates, shear stress tolerance, water activity ($a_w \le 0.60$), and vacuum liquid coating fat absorption efficiency.
Two-bowl palatability trial validation alongside Near-Infrared Spectroscopy (NIR), HPLC micro-nutrient testing, and enzymatic allergen verification prior to full-scale approval.
Full manufacturing under strict HACCP protocols. In-line metal detection, optical kibble sorting, retained batch sampling, and issuing of official Certificate of Analysis (CoA).
Customs documentation, DEFRA export health certificates, phytosanitary clearance, container loading optimizations, and localized multilingual regulatory artwork validation.
Every therapeutic recipe is formulated and validated by qualified animal nutrition experts and veterinary advisors, ensuring medical soundess and compliance with European and global dietary standards.
To eliminate cross-contact risks in clinical hypoallergenic lines, our manufacturing systems utilize intensive line purges, enzymatic washing cycles, and mandatory DNA testing on subsequent production lots.
Our advanced post-extrusion vacuum coating ensures heat-sensitive therapeutic ingredients (probiotics, essential fatty acids, joint protectants, enzymes) are absorbed deep into the kibble matrix without heat degradation.
We handle complex international veterinary regulations, offering DEFRA health certification, origin certificates, moisture/microbiology testing, and multilingual packaging compliance support.
Addressing crucial technical, regulatory, and manufacturing inquiries commonly evaluated by enterprise procurement teams, private label buyers, and veterinary distributors.
Clinical Veterinary Pet Nutrition is specifically engineered to target diagnosed physiological conditions, pathology management, or systemic organ support (such as chronic kidney disease, acute gastroenteritis, or severe dermatological allergies). Unlike general wellness pet foods, clinical formulations adhere to tight nutrient windows, restricted bio-available protein panels, controlled mineral dynamics (e.g., phosphorus, sodium, calcium-phosphorus ratios), and scientifically validated bio-active additives. Every production batch undergoes rigorous batch-level analytical verification to meet strict veterinary standards.
Our UK manufacturing facilities maintain zero-cross-contamination protocols for specialized clinical lines. Hypoallergenic and single-novel-protein formulations undergo dedicated production scheduling following verified high-pressure line purging and enzymatic cleaning validation. We utilize ELISA (Enzyme-Linked Immunosorbent Assay) testing and DNA testing on raw ingredients and finished kibble to verify the complete absence of non-declared animal proteins or common environmental allergens.
Yes. Our veterinary nutritionists and regulatory experts model all therapeutic recipes to dual-compliant nutrient windows that respect European (FEDIAF) guidelines and North American (AAFCO) profiles simultaneously, while adhering to specific medicinal feed regulations across target export territories such as the EU, US, GCC, and East Asia.
Full batch extrusion runs for clinical dry kibble typically begin at standard production minimums per single recipe to protect micro-nutrient accuracy and kibble structural integrity. Pilot trial runs and modular clinical supplement packs can be scheduled in smaller trial volumes. A complete development cycle—from clinical brief, raw material sourcing, and lab trial to analytical testing, palatability sign-off, and packaging approval—ranges between 8 to 16 weeks.
Inappetence is a major challenge in veterinary clinical management. We utilize advanced thermal vacuum coating systems that infuse high-grade natural hydrolysates, refined omega-3 rich lipids, and specialized palatants into the kibble core without degrading heat-sensitive vitamins or functional bio-actives, ensuring high voluntary intake even in compromised pets.
Yes. Our clinical care range includes veterinary-grade urinary tract support formulas engineered to control urinary pH and relative supersaturation (RSS) values. By balancing magnesium, phosphorus, and calcium intake while enhancing renal water clearance, our recipes effectively assist in dissolving struvite uroliths and minimizing the recurrence of calcium oxalate crystals.
Absolutely. We regularly work with brand owners who provide proprietary functional additives, such as proprietary botanical blends, specific prebiotics, or patented joint health compounds. Our technical team conducts compatibility and thermal stability audits to ensure your proprietary ingredients remain stable throughout our extrusion and coating processes.
Connect with our technical formulation directors, regulatory experts, and international contract manufacturing team today. Receive tailored advice on recipe design, minimum order volumes, and global export support.
